Close Menu


Affymetrix's shares increased nearly 50 percent during the month on the strength of its Q2 results, while Myriad and Celera each dropped more than 20 percent as they said their respective quarterly revenues would be lower than previously expected.

Eppendorf alleges that Nanosphere's Verigene instruments and kits infringe US Patent No. 7,321,829, "Method for the identification and/or the quantification of a target compound obtained for a biological sample upon chips."

James White, Chris Gleeson, Faiz Kayyem, Tim Dehne

Movers & Shakers: Jul 16, 2009


Tim Dehne

The firm has been cleared by FDA to include data from two studies that shows its Respiratory Viral Panel can be an effective aid in detecting the virus.

The Life Technologies unit said that its new Prodigy system should support the use of human leukocyte antigen testing in histocompatibility research, vaccine and drug development, and disease-association studies.

Heiner Dreismann, Michael Pintek, Jeremy Bridge-Cook, Nancy Krunic

New Products: Jun 18, 2009


Luminex, Fluidgm, GE Healthcare

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Luminex, BD, and Prodesse all immediately complied with FDA's instructions in removing statements from their websites related to tests for the 2009 H1N1 flu virus.


A genetic genealogy analysis helped secure the release of a California man from prison after getting his murder conviction overturned, the Guardian reports.

Technology Review discusses the concerns that come along with the ability to quickly synthesize viruses like SARS-CoV-2.

Researchers have uncovered large bacteriophages whose genomes include translational machinery, Live Science reports.

In PNAS this week: role for Myc in alternative splicing regulation in prostate cancer, variation in methylation in Arabidopsis, and more.